Prenalterol

Prenalterol is a cardiac stimulant that functions as a beta-1 adrenergic receptor agonist. It was developed in the 1980s as a treatment for heart failure and angina pectoris, but its use has been limited due to the risk of tachycardia.

Pharmacology

Prenalterol works by stimulating the beta-1 adrenergic receptors in the heart, which increases cardiac output and decreases systemic vascular resistance. This results in improved blood flow and reduced symptoms of heart failure and angina.

Clinical Use

Prenalterol has been used in the treatment of heart failure and angina pectoris. However, its use has been limited due to the risk of tachycardia, a condition characterized by an abnormally fast heart rate.

Side Effects

The most common side effect of prenalterol is tachycardia. Other potential side effects include palpitations, chest pain, and dizziness. In rare cases, prenalterol can cause cardiac arrhythmia, a serious condition that can lead to cardiac arrest.

History

Prenalterol was developed in the 1980s as a potential treatment for heart failure and angina pectoris. However, its use has been limited due to the risk of tachycardia.

See Also

• Beta-1 adrenergic receptor
• Heart failure
• Angina pectoris
• Tachycardia

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia

• 
  Prenalterol
• 
  Prenalterol synthesis